Key result
Inappropriate dosing of direct oral anticoagulants was observed in 24.9% of patients with atrial fibrillation.
Why the study?
Inappropriate DOAC dosing increases adverse clinical outcomes in AF, prompting evaluation of its prevalence and associated factors in real-life settings.
Cross-Sectional (n=2,004)
Yes
Approximately one-quarter of patients with atrial fibrillation receive inappropriate doses of direct oral anticoagulants, highlighting the need for improved adherence to dosing guidelines, especially in older patients and those with chronic kidney disease.
Answers are grounded in this paper and cite their sources.
May warrant closer DOAC dosing review in AF; leaves open whether targeted interventions improve adherence.
Abstract Purpose: Inappropriate dosing of direct oral anticoagulants is associated with an increased risk of stroke, systemic embolism, major bleeding, cardiovascular hospitalization, and death in patients with atrial fibrillation. The main goal of the study was to determine the prevalence and associated factors of inappropriate dosing of direct oral anticoagulants in real-life settings.Methods: This study was a multicenter, cross-sectional, observational study that included 2,004 patients with atrial fibrillation. The study population was recruited from 41 cardiology outpatient clinics between January and May 2021. The main criteria for inappropriate direct oral anticoagulant dosing were defined according to the recommendations of the European Heart Rhythm Association. Results: The median age of the study population was 72 years and 58% were women. Nine hundred and eighty-seven patients were prescribed rivaroxaban, 658 apixaban, 239 edoxaban, and 120 dabigatran. A total of 498 patients (24.9%) did not receive the appropriate dose of direct oral anticoagulants. In a logistic regression model, advanced age, presence of chronic kidney disease, presence of permanent atrial fibrillation, prescription of reduced doses of direct oral anticoagulants, prescription of edoxaban treatment, concomitant use of amiodarone treatment, and non-use of statin treatment were significantly associated with potentially inappropriate dosing of direct oral anticoagulants. Conclusion: The study demonstrated that the prevalence of inappropriate direct oral anticoagulant dosing according to the European Heart Rhythm Association recommendations was 24.9% in patients with atrial fibrillation. Several demographic and clinical factors were associated with the inappropriate prescription of direct oral anticoagulants.
No takes yet. Share an insight, caveat, or question.
Kocabaş et al. (2022) conducted a cross-sectional in Atrial fibrillation (n=2,004). Direct oral anticoagulants was evaluated on Prevalence of inappropriate dosing of direct oral anticoagulants. Inappropriate dosing of direct oral anticoagulants was observed in 24.9% of patients with atrial fibrillation.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: